Recent FDA approvals
Desmopressin tablets 0.1 and 0.2 mg (equiv to DDAVP tablets).
First-time generic approvals
Desmopressin tablets 0.1 and 0.2 mg (equiv to DDAVP tablets)
BARR
Isoniazid injection 100 mg/mL packaged in 10 mL multiple-dose vials (equiv to Nydrazid injection)
SABEX 2002
Alclometasone cream 0.05% (equiv to Aclovate cream)
ALTANA
Fexofenadine capsules 60 mg (equiv to Allegra capsules)
BARR
Doxycycline tablets and capsules 150 mg (equiv to Monodox capsules)
PAR
Pyridostigmine tablets 30 mg (equiv to pyridostigmine tablets)
BARR
Rifampin and isoniazid capsules 300/150 mg (equiv to Rifamate capsules)
WEST-WARD
Employers Face Barriers With Adopting Biosimilars
March 1st 2022Despite the promise of savings billions of dollars in the United States, adoption of biosimilars has been slow. A roundtable discussion among employers highlighted some of the barriers, including formulary design and drug pricing and rebates.
